Search This Blog

Thursday, October 30, 2014

Lilly Shares Insights from Decade-Long Technology Transfer Experience (NYSE:LLY)

INDIANAPOLISOct. 30, 2014 /PRNewswire/ -- Today Eli Lilly and Company (NYSE: LLY) published details of its long-standing technology transfer program to increase the global supply of medicines for multidrug-resistant tuberculosis (MDR-TB). Begun in 2003, the effort included Lilly donating manufacturing technology and know-how for two antibiotics to pharmaceutical manufacturers in ChinaIndiaRussia and South Africa - all MDR-TB 'hot spots.' It also served as the foundation for the Lilly MDR-TB Partnership, the company's largest-ever philanthropic effort.



Lilly Shares Insights from Decade-Long Technology Transfer Experience (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.